The trial conducted by Western University of Health Sciences aimed to evaluate the potential of OMT to augment the immune response to mRNA COVID-19 vaccines. Given the ongoing concerns regarding vaccine efficacy against emerging variants and waning immunity, a successful outcome could position OMT as a complementary therapy in vaccination protocols, potentially expanding market opportunities in immunotherapy and preventive healthcare. The study's findings may attract interest from vaccine manufacturers and healthcare providers seeking to enhance vaccine effectiveness, thereby influencing competitive dynamics in the immunization landscape. Additionally, the collaboration with various osteopathic organizations may facilitate broader acceptance and integration of OMT in clinical practice, enhancing the commercial viability of this approach.